Phathom Pharmaceuticals (PHAT) Debt Ratio (2019 - 2026)
Phathom Pharmaceuticals (PHAT) posted quarterly Debt Ratio of 0.5 for Q2 2026, down 38.62% year-over-year from 0.82 in Q2 2025, and down 6.19% quarter-over-quarter from 0.54 in Q1 2026.
Phathom Pharmaceuticals (PHAT) Debt Ratio (2019 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has reported Debt Ratio for 8 consecutive years, with 0.5 the latest figure, recorded in Q2 2026.
- In Q2 2026, Debt Ratio fell 38.62% year-over-year to 0.5; the TTM figure through Jun 2026 stood at 0.5 (down 38.62% YoY), while the FY2025 annual figure was 0.81, up 51.55% from the prior year.
- Debt Ratio fell to 0.5 in Q2 2026 per PHAT's latest filing, from 0.54 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.86 in Q3 2025 and bottomed at 0.33 in Q4 2023.
- Historically, Debt Ratio has averaged 0.56 across 5 years, with a median of 0.53 in 2024.
- Annual changes were most pronounced in 2022 — Debt Ratio soared 217.78% — and 2023, when it plunged 42.38%.
- Phathom Pharmaceuticals' Debt Ratio stood at 0.58 in 2022, then slumped by 42.38% to 0.33 in 2023, then jumped by 59.84% to 0.53 in 2024, then jumped by 51.55% to 0.81 in 2025, then plunged by 37.63% to 0.5 in 2026.
- Business Quant data shows PHAT's Debt Ratio at 0.5 in Q2 2026, 0.54 in Q1 2026, and 0.81 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Phathom Pharmaceuticals | 767.07 Mn | 581.73 Mn | 59.18 Mn | 0.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.50 |
| Mar 31, 2026 | 0.54 |
| Dec 31, 2025 | 0.81 |
| Sep 30, 2025 | 0.86 |
| Jun 30, 2025 | 0.82 |
| Mar 31, 2025 | 0.69 |
| Dec 31, 2024 | 0.53 |
| Sep 30, 2024 | 0.45 |
| Jun 30, 2024 | 0.55 |
| Mar 31, 2024 | 0.42 |
| Dec 31, 2023 | 0.33 |
| Sep 30, 2023 | 0.42 |
| Jun 30, 2023 | 0.37 |
| Mar 31, 2023 | 0.67 |
| Dec 31, 2022 | 0.58 |
| Sep 30, 2022 | 0.46 |
| Jun 30, 2022 | 0.43 |
| Mar 31, 2022 | 0.61 |
| Dec 31, 2021 | 0.47 |
| Sep 30, 2021 | 0.39 |